The AFG3L2 gene helps cells keep their energy-making machinery working by clearing damaged proteins inside mitochondria, the parts of cells that produce energy. This gene plays an important role in protecting nerve cells, so if it does not work properly, the brain, eyes, and nerves may be affected most. Harmful variants in the AFG3L2 gene are linked to conditions that can cause balance and coordination problems, muscle stiffness or weakness, unusual eye movements, or vision changes. Symptoms can vary a lot, even within the same family.
What is a gene?
A gene is a stretch of DNA that gives your cells instructions they can use to make molecules or guide processes in the body. Some genes hold the code for proteins, the working parts of cells. Others mainly regulate when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and functions, and they can shape how you respond to food, stress, or medications. You can find more on this topic in the LearnHub.
Overview
AFG3L2Gene function
What if the gene works
The AFG3L2 gene helps mitochondria, the parts of cells that make energy, keep their proteins in good working order. This supports steady energy production, especially in nerve and muscle cells.
Risk
What if the gene does not work
Variants in the AFG3L2 gene most often affect balance and coordination, with symptoms starting from childhood to adulthood and ranging from mild to more limiting. Some variants also affect vision or cause earlier developmental and nerve problems.
Treatment
What does that mean for your treatment
No AFG3L2-specific treatment or drug selection approach is currently established for pathogenic or loss-of-function variants in the AFG3L2 gene. Research is exploring how disrupted mitochondrial protein quality control in AFG3L2-related conditions might guide future targeted therapies, but this has not yet changed routine care.
Conditions associated with AFG3L2
Gene function
What if the gene works
Your cells depend on healthy mitochondria, the parts of cells that make usable energy. In simple terms, AFG3L2 gene function centers on keeping mitochondrial proteins in good working order so energy production stays steady. It does this by helping with protein cleanup, protein processing, and the overall balance of the inner mitochondrial membrane.
Inside mitochondria, the AFG3L2 gene helps break down proteins that are damaged, extra, or no longer needed. This cleanup keeps the mitochondrial workspace orderly and supports steady cell activity.
Some mitochondrial proteins are made in an inactive form and need small cuts before they can work properly. The AFG3L2 gene helps carry out those finishing steps so key cell parts are ready for use.
By maintaining protein machinery inside mitochondria, the AFG3L2 gene supports the steps cells use to turn food into usable energy. This helps cells with high energy needs, including nerve and muscle cells, work smoothly.
The AFG3L2 gene helps preserve the inner membrane of mitochondria, where much of energy production takes place. This supports normal organization inside these energy making parts of the cell and helps daily cell work stay coordinated.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant can more substantially change how a gene functions and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the AFG3L2 gene can alter the shape or stability of a protein machine inside mitochondria, the parts of cells that make energy, and this can weaken protein cleanup and quality control. In understanding how AFG3L2 gene variants affect protein function, some changes only partly reduce activity, while more disruptive variants can strongly lower or abolish it or disrupt binding with partner proteins. Greater loss of function is linked with earlier onset or broader neurologic features in some people.
How variants are linked to conditions
Pathogenic variants in the AFG3L2 gene are best known for causing spinocerebellar ataxia type 28, and AFG3L2 gene variants linked to spinocerebellar ataxia type 28 can cause gradually worsening balance, coordination, speech, and eye movement problems. Other damaging AFG3L2 variants, including some inherited from both parents or arising new in a child, can lead to earlier-onset brain and nerve conditions with developmental delay, seizures, muscle stiffness, weakness, or vision loss from optic nerve involvement.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a routine part of human biology. Most do not directly affect health and instead reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental factors also play a role. In some situations, though, one well characterized variant in a particular gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
For AFG3L2-related conditions, risk is mostly shaped by whether you carry a disease-causing change in the AFG3L2 gene and how it runs in your family. Specific lifestyle or environmental factors that clearly increase or reduce that risk have not been firmly confirmed.
Inheritance of AFG3L2 variants
The inheritance pattern for AFG3L2-related conditions can differ depending on the specific condition and variant type. Many AFG3L2 gene variants linked to spinocerebellar ataxia type 28 follow an autosomal dominant pattern, so a parent carrying the variant has a 50% chance of passing it to each child. Other AFG3L2 gene changes are inherited in an autosomal recessive way, which means a child must inherit one altered copy from each parent. This means how AFG3L2 variants are inherited depends on the exact diagnosis tied to the gene change.
What does my AFG3L2 result mean for my family?
Some AFG3L2 results are linked to conditions that can run in families, and the family meaning depends on the exact condition tied to that result. In some families, a close relative such as a parent, brother, sister, or child may also carry the same gene change, while in other situations relatives may be healthy carriers. Because AFG3L2 is tied to more than one inherited condition, family testing questions are best considered in light of the specific result.
Genetic information
Genetic testing
How you find out about variants
Doctors can look for changes in the AFG3L2 gene through AFG3L2 genetic testing, usually using a blood sample or saliva. The lab reads the gene’s DNA sequence to check for variants that may help explain symptoms or a family history of ataxia or related nerve problems. Results can confirm a diagnosis in some families or show that no relevant variant was found.
When should I consider getting a genetic test?
Consider genetic testing if you or close relatives have a worsening balance problem, unsteady walking, slurred speech, unusual eye movements, or a diagnosis of inherited ataxia. Testing can help show whether a change in the AFG3L2 gene is the cause and may clarify family risk.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but what it can tell you varies with the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same drug works well for one person, has less effect in another, or causes more side effects in someone else. Part of the reason is that inherited differences can change how the body absorbs, breaks down, or responds to a medication. These differences are common and can influence both how well a treatment works and how sensitive a person is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way people respond to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can play a part in how strongly a drug works or in how the body handles it. This understanding can support treatment decisions that are more informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the AFG3L2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so questions about medicines, side effects, or new symptoms are best discussed with your doctor or pharmacist.
History
The AFG3L2 gene entered medical genetics in the 2000s through studies of families with inherited balance and coordination problems. Inheritance patterns were noticed long before the gene was identified. A major step came in 2010, when researchers linked variants in the AFG3L2 gene to spinocerebellar ataxia type 28, helping explain a form of ataxia that ran in some families. Soon after, other reports connected different AFG3L2 gene variants with childhood onset neurological conditions, broadening the picture. As medical science evolved, so did understanding of this gene. What first seemed like a single rare ataxia became recognized as part of a wider spectrum of inherited conditions affecting movement and nerve function.